Glenmark Pharmaceuticals Limited
FDA inspection history in Chhatrapati Sambhajinagar (previously known as Aurangabad), India, 2022
- 1
- Form 483
Every document, by year
- Form 483
2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One Form 483, at Chhatrapati Sambhajinagar (previously known as Aurangabad), India.
Cited most
Across all Glenmark Pharmaceuticals Limited observations on file
- 21 CFR 211.192Production record review1
The complete Glenmark Pharmaceuticals Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Chhatrapati Sambhajinagar (previously known as Aurangabad), India
One Form 483 · 2022 · 1 observation
Latest: Form 483, Jul 1, 2022 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-07-01 | 483 Form 483 | Chhatrapati Sambhajinagar (previously known as Aurangabad), India | 1 | $99 |
Investigators on these documents
FEI number 3009915929 · most recent document Jul 1, 2022
About Glenmark Pharmaceuticals Limited
How many FDA Form 483s has Glenmark Pharmaceuticals Limited received?
FDA Intel has 1 Form 483 on file for Glenmark Pharmaceuticals Limited; the most recent is dated Jul 1, 2022.
When was Glenmark Pharmaceuticals Limited last inspected by FDA?
The most recent FDA inspection document on file for Glenmark Pharmaceuticals Limited is a Form 483 dated Jul 1, 2022, for the site in Chhatrapati Sambhajinagar (previously known as Aurangabad), India.
What did FDA cite at Glenmark Pharmaceuticals Limited?
The regulations cited most in the observations on file for Glenmark Pharmaceuticals Limited are 21 CFR 211.192 (Production record review), 1 time.